RECURRENT FIBROLAMELLAR CARCINOMA

Clinical trials for RECURRENT FIBROLAMELLAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT FIBROLAMELLAR CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT FIBROLAMELLAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with tough cancers: experimental drug combo enters trial

Disease control Recruiting now

This study is testing a new two-drug combination for children, teens, and young adults whose solid tumors or a rare liver cancer called fibrolamellar carcinoma have come back or stopped responding to standard treatments. The main goals are to find the safest and most effective do…

Matched conditions: RECURRENT FIBROLAMELLAR CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

RECURRENT FIBROLAMELLAR CARCINOMA

Get alerted when new RECURRENT FIBROLAMELLAR CARCINOMA trials appear

New hope for kids with tough cancers: experimental drug combo enters trial